Published in Aliment Pharmacol Ther on July 01, 2002
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut (2005) 3.86
Cancer in inflammatory bowel disease. World J Gastroenterol (2008) 2.12
Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut (2004) 1.87
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Treating rheumatic patients with a malignancy. Arthritis Res Ther (2011) 1.03
An old herbal medicine with a potentially new therapeutic application in inflammatory bowel disease. Int J Clin Exp Med (2011) 0.90
Small bowel adenocarcinoma in Crohn's disease: a case report and review of literature. World J Gastroenterol (2006) 0.90
Thiopurines in inflammatory bowel disease revisited. World J Gastroenterol (2013) 0.88
Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine. Dig Dis Sci (2007) 0.87
Medical treatment of ulcerative colitis. Clin Colon Rectal Surg (2004) 0.86
Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis. PLoS One (2013) 0.83
Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease. Expert Rev Clin Immunol (2010) 0.80
Gut-liver axis plays a role in hepatocarcinogenesis of patients with Crohn's disease. World J Gastroenterol (2011) 0.80
Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2. Hematol Rep (2012) 0.79
Primary CD56+ NK/T-cell lymphoma of the rectum accompanied with refractory ulcerative colitis. J Gastroenterol (2008) 0.79
Current use of immunosuppressive agents in inflammatory bowel disease patients in East China. World J Gastroenterol (2009) 0.79
Renal cell carcinoma in a patient with cystinosis and inflammatory bowel disease: a case report. Pediatr Nephrol (2008) 0.78
Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain. World J Gastroenterol (2013) 0.77
Papillary thyroid cancer and ulcerative colitis. Gastroenterol Hepatol Bed Bench (2013) 0.76
Quality of care for patients with inflammatory bowel disease in East China. World J Gastroenterol (2008) 0.75
Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy. BMJ Case Rep (2014) 0.75
Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis. World J Gastroenterol (2015) 0.75
Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis. Gastroenterol Res Pract (2016) 0.75
A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease. J Gastroenterol (2016) 0.75
Hematologic malignancies in the Japanese patients with inflammatory bowel disease. J Gastroenterol (2013) 0.75
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut (1989) 4.59
Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet (1996) 4.33
Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol (1973) 4.32
Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet (1995) 4.12
Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet (1996) 4.09
Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet (1974) 4.06
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol (1983) 3.21
In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med (2000) 3.04
Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut (1984) 2.74
T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens. Clin Exp Immunol (1981) 2.68
Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol (1983) 2.49
Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut (1989) 2.44
Immunohistological characterisation of intraepithelial lymphocytes of the human gastrointestinal tract. Gut (1981) 2.38
Cap polyposis--an unusual cause of diarrhoea. Gut (1993) 2.38
Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease. Clin Exp Immunol (1983) 2.34
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J (1974) 2.24
Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut (1992) 2.15
Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut (1989) 2.06
Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 2.04
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut (2002) 2.00
Predicting outcome in severe ulcerative colitis. Gut (1996) 1.99
The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol (1979) 1.98
Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. Clin Exp Immunol (1988) 1.95
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
Food intolerance and the irritable bowel syndrome. Gut (1989) 1.88
The genetics of inflammatory bowel disease. Gut (1997) 1.83
The association of autoimmune disorders with inflammatory bowel disease. Q J Med (1989) 1.80
Genetics of inflammatory bowel disease. Gut (1994) 1.79
Clinical patterns of familial inflammatory bowel disease. Gut (1996) 1.76
Perianal Crohn's disease. Br J Surg (2004) 1.73
Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1989) 1.69
Crohn's disease and pregnancy. Gut (1984) 1.66
Role of the faecal stream in the maintenance of Crohn's colitis. Gut (1985) 1.63
A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology (2001) 1.60
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58
Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut (1998) 1.58
T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut (1983) 1.57
Effect of heparin on polymerase chain reaction. Lancet (1994) 1.55
Olsalazine in active ulcerative colitis. Br Med J (Clin Res Ed) (1985) 1.55
Immune-complex mediated colitis in rabbits. An experimental model. Gut (1978) 1.54
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther (2003) 1.54
Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut (2000) 1.52
Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology (1997) 1.52
Susceptibility loci in inflammatory bowel disease. Lancet (1996) 1.49
Assessment of fat malabsorption. J Clin Pathol (1983) 1.49
Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut (1986) 1.49
The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol (2001) 1.49
Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab (1997) 1.48
Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing. J Clin Pathol (1980) 1.47
Chronic immune colitis in rabbits. Gut (1979) 1.46
Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut (2003) 1.42
Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut (1992) 1.39
Mucosal characteristics of pelvic ileal pouches. Gut (1991) 1.38
Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia (2003) 1.37
Cytokine gene expression in HIV-infected intestinal mucosa. AIDS (1994) 1.37
T cells in peripheral blood after gluten challenge in coeliac disease. Gut (2005) 1.36
C3 metabolism in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 1.34
Ten-year experience of strictureplasty for obstructive Crohn's disease. Br J Surg (1989) 1.33
Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease. Gut (2003) 1.31
Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut (2005) 1.30
The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Inflamm Bowel Dis (1998) 1.30
Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial. Br Med J (1972) 1.28
Ulcerative colitis and persistent liver dysfunction. Q J Med (1983) 1.27
Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther (2001) 1.25
Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon. J Clin Pathol (1987) 1.25
Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun (2000) 1.24
Lymphocyte and macrophage subpopulations in pelvic ileal pouches. Gut (1991) 1.23
Inhibition of leucocyte motility by drugs used in ulcerative colitis. Gut (1981) 1.23
Changing pattern of gastric cancer in Oxfordshire. Gut (1992) 1.23
Mobilisation of enterocyte fat stores by oral glucose in humans. Gut (2003) 1.22
Characterization of antigen-presenting activity of intestinal mononuclear cells isolated from normal and inflammatory bowel disease colon and ileum. Immunology (1988) 1.21
Cancer surveillance in ulcerative colitis. Br J Surg (2005) 1.20
Smoking benefits celiac sprue and pouchitis: implications for nicotine therapy? Gastroenterology (1997) 1.19
NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut (2001) 1.19
Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology (2000) 1.19
One year follow-up of an emergency department protocol for abused women. Aust N Z J Public Health (1999) 1.18
Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. Hum Pathol (1985) 1.17
Circulating antibodies to cow's milk proteins in ulcerative colitis. Gut (1972) 1.16
Linkage analysis of candidate regions for coeliac disease genes. Hum Mol Genet (1997) 1.15
Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut (1988) 1.15
Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut (2003) 1.15
Outcome of 200 restorative proctocolectomy operations: the John Radcliffe Hospital experience. Br J Surg (1997) 1.14
Immunology of inflammatory bowel disease. Scand J Gastroenterol Suppl (1985) 1.14
Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum (2001) 1.13
The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease. Aliment Pharmacol Ther (2008) 1.12
Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther (2004) 1.12
Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis. Gastroenterology (1982) 1.10
Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther (2007) 1.09
Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells. Clin Sci (Lond) (1990) 1.09
Inflammatory bowel disease and the X chromosome. QJM (1996) 1.08
Outcome evaluation of an emergency department protocol of care on partner abuse. Aust N Z J Public Health (1998) 1.08
Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis. Gut (1991) 1.08
Pulmonary function in inflammatory bowel disease. Digestion (1978) 1.08
Effects of the faecal stream and stasis on the ileal pouch mucosa. Gut (1991) 1.08
In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease. Scand J Gastroenterol (1991) 1.08